Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis | RadioGraphics
Aquaporin-4-positive neuromyelitis optica spectrum disorder linked to glial cell dysfunction - American Academy of Ophthalmology
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies | Nature Reviews Neurology
The spectrum of neuromyelitis optica - ScienceDirect
Aquaporin 4 and neuromyelitis optica - The Lancet Neurology
Beyond Aquaporin and MOG- Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders | Else Kröner-Fresenius-Stiftung
SciELO - Brasil - The expanded spectrum of neuromyelitis optica: evidences for a new definition The expanded spectrum of neuromyelitis optica: evidences for a new definition
IJMS | Free Full-Text | Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives | HTML
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials | Nature Reviews Neurology
Are Zika virus cross-reactive antibodies against aquaporin-4 associated to Neuromyelitis Optica Spectrum Disorder? - ScienceDirect
Pathogenesis and drug targets in NMOSD. Aquaporin 4 (AQP4)-specific B... | Download Scientific Diagram
JCI - Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica | Nature Reviews Neurology
Neuromyelitis Optica, Part 2: Pathogenesis | Multiple Sclerosis Discovery Forum
Neuromyelitis optica (NMO) pathogenic mechanisms mediated by complement... | Download Scientific Diagram
Aquaporin 4 and neuromyelitis optica - The Lancet Neurology
Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations | Nature Reviews Neurology
Review: Recent advances in the understanding of the pathophysiology of neuromyelitis optica spectrum disorder - Chang - 2020 - Neuropathology and Applied Neurobiology - Wiley Online Library
Frontiers | Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice
Treatment and outcome of aquaporin-4 antibody–positive NMOSD | Neurology Neuroimmunology & Neuroinflammation
New Therapeutic Landscape in Neuromyelitis Optica | SpringerLink
Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in Neuromyelitis Optica: A cell-based study - ScienceDirect
Neuromyelitis Spectrum Disorders - Mayo Clinic Proceedings
